Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome: A Narrative Review
Crossref DOI link: https://doi.org/10.1007/s11655-022-3513-4
Published Online: 2022-05-04
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yuan, Jia-yao
Fu, Yu
Feng, Zhi-hai
Sang, Feng
Shao, Ming-yi
Li, Lei-lei
Text and Data Mining valid from 2022-05-04
Version of Record valid from 2022-05-04
Article History
Accepted: 31 October 2021
First Online: 4 May 2022
Conflict of Interest
: All authors declare no conflicts of financial interest.